EGF Theramed Health Corp.
TMED
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 44.64% | -16.46% | -3.85% | 23.97% | 18.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.64% | -16.46% | -3.85% | 19.60% | 18.07% |
| Operating Income | -44.64% | 16.46% | 3.85% | -19.60% | -18.07% |
| Income Before Tax | -71.46% | 66.36% | -51.88% | -1,735.26% | 4.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -71.46% | 67.03% | -51.88% | -2,470.27% | 4.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 177.14% | -88.00% | 569.23% | -153.23% | -52.05% |
| Net Income | -63.86% | 64.81% | -28.32% | -2,682.74% | -2.53% |
| EBIT | -44.64% | 16.46% | 3.85% | -19.60% | -18.07% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -64.29% | 64.75% | -29.17% | -2,633.33% | 0.00% |
| Normalized Basic EPS | -60.00% | 62.86% | 0.00% | -2,577.42% | -4.17% |
| EPS Diluted | -64.29% | 64.75% | -29.17% | -2,633.33% | 0.00% |
| Normalized Diluted EPS | -60.00% | 62.86% | 0.00% | -2,577.42% | -4.17% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.70% | 1.99% | 1.98% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.70% | 1.99% | 1.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |